SELLAS Life Sciences Group, Inc. Treasury Stock, Value
SELLAS Life Sciences Group, Inc. (SLS) had Treasury Stock, Value of $3.85 million as of 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2017-11-09
- 2017-09-30: Treasury Stock, Value $3.85M.
- 2017-06-30: Treasury Stock, Value $3.85M.
- 2017-03-31: Treasury Stock, Value $3.85M.
- 2016-12-31: Treasury Stock, Value $3.85M.
| Period end | Treasury Stock, Value |
|---|---|
| 2017-09-30 | $3.85M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $3.85M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $3.85M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.85M 10-Q · filed 2017-11-09 |
| 2016-09-30 | $3.85M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $3.85M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $3.85M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $3.85M 10-K · filed 2017-03-15 |
| 2015-09-30 | $3.85M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $3.85M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $3.85M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $3.85M 10-K/A · filed 2016-04-15 |
| 2014-09-30 | $3.85M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $3.85M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $3.85M 10-Q · filed 2014-05-06 |
| 2013-12-31 | $3.85M 8-K · filed 2015-12-04 |
| 2013-09-30 | $3.85M 10-Q/A · filed 2013-11-07 |
| 2013-06-30 | $3.85M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $3.85M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $3.85M 10-K · filed 2014-03-17 |
| 2012-09-30 | $3.85M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $3.85M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $3.85M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $3.85M 10-K · filed 2013-03-12 |
| 2011-09-30 | $3.85M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $3.85M 10-Q/A · filed 2011-10-28 |
| 2010-12-31 | $3.85M 10-K · filed 2012-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |